In yesterday’s Wall Street session, Medifast Inc (NYSE:MED) shares traded at $22.83, up 0.31% from the previous session.
MED stock price is now -26.44% away from the 50-day moving average and -60.56% away from the 200-day moving average. The market capitalization of the company currently stands at $249.76M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $82, Stephens recently initiated with Equal-Weight rating for Medifast Inc (NYSE: MED). On November 04, 2022, DA Davidson Downgraded its previous ‘Buy’ rating to ‘Neutral’ on the stock reducing its target price from $278 to quote $106, while ‘Jefferies’ rates the stock as ‘Hold’
In other news, SCHLACKMAN SCOTT, Director sold 4,053 shares of the company’s stock on Mar 08 ’24. The stock was sold for $159,866 at an average price of $39.44. Upon completion of the transaction, the Director now directly owns 7,785 shares in the company, valued at $0.18 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 07 ’23, Director BROWN JEFFREY J bought 58 shares of the business’s stock. A total of $4,020 was incurred on buying the stock at an average price of $68.89. This leaves the insider owning 5,784 shares of the company worth $0.13 million. A total of 2.67% of the company’s stock is owned by insiders.
During the past 12 months, Medifast Inc has had a low of $22.68 and a high of $109.52. As of last week, the company has a debt-to-equity ratio of 0.10, a current ratio of 2.84, and a quick ratio of 2.25. According to the stock market information, the enterprise value for the company is $108313440, which is based on a 3.68 price-to-earnings ratio, a 0.18 price-to-earnings-growth ratio, and a beta of 1.16. The fifty day moving average price for MED is $30.803 and a two-hundred day moving average price translates $57.53435 for the stock.
The latest earnings results from Medifast Inc (NYSE: MED) was released for 2024-03-31. According to the Personal Services Company, earnings per share came in at 2.77, beating analysts’ expectations of 1.44 by 1.33. This compares to $3.67 EPS in the same period last year. The net profit margin was 7.55% and return on equity was 35.49% for MED. The company reported revenue of $174.74 million for the quarter, compared to $348.98 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -49.93 percent. For the current quarter, analysts expect MED to generate $157.35M in revenue.
